Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Blueprint Medicines Corp changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 8 | 6 | −2 |
| Shares | 26.9K | 326 | −26.6K (−98.8%) |
| Value | $2.57M | $38.6K | −$2.54M (−98.5%) |
New holders (1)
Institutions that held Blueprint Medicines Corp at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Golden State Equity Partners | 11 | $0 | 0.00% |
Sold out (3)
Institutions that held Blueprint Medicines Corp at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| DekaBank Deutsche Girozentrale | 25,883 | $2.57M |
| GAMMA Investing LLC | 271 | $0 |
| Flagship Wealth Advisors, LLC | 443 | $0 |